Usefulness of QT-interval parameters for cardiovascular risk stratification in type 2 diabetic patients with arterial hypertension

Journal of Human Hypertension

Volumn 19, Issue 3, 2005, Pages 241-249

  Salles, Gil F ^a,b   Deccache, W ^a   Cardoso, C R L ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Arterial hypertension; Diabetes mellitus; Electrocardiography; Hypertrophy; Mortality; QT interval; Risk factors

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CALCULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE DURATION; FATALITY; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; PROSPECTIVE STUDY; QT INTERVAL; RISK ASSESSMENT; SURVIVAL; TRIACYLGLYCEROL BLOOD LEVEL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; BLOOD PRESSURE; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 14944354563     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001815     Document Type: Article

References (37)

1. Somberg JC, Molnar J. Usefulness of QT dispersion as an electrocardiographically derived index. Am J Cardiol 2002; 89 291-294.
2. Zabel M, Klingenheben T, Franz MR, Hohnloser SH. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction. Results of a prospective, long-term, follow-up study. Circulation 1998; 97: 2543-2550.
3. Brendorp B et al. QT dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function. Circulation 2001; 103: 831-835.
4. Salles G et al. Prognostic value of QT interval parameters for mortality risk stratification in Chagas'-disease: results of a long-term follow-up study. Circulation 2003; 108: 305-312.
5. Cardoso C, Salles G, Deccache W. Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study. J Diab Comp 2003; 17: 169-178.
6. de Bruyne MC et al. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. Eur Heart J 1999; 20: 278-284.
7. Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000; 36 1749-1766.
8. Mayet J et al. Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension 1996; 28: 791-796.
9. Oikarinen L et al. Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. J Hypertens 2001; 19: 1883-1891.
10. Galinier M et al. Prognostic value of ventricular arrhythmias in systemic hypertension. J Hypertens 1997; 15: 1779-1783.
11. Saadeh AM, Jones JV. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up. J Hum Hypertens 2001; 15: 677-680.
12. Oikarinen L et al. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy. The losartan intervention for end point reduction in hypertension study. Hypertension 2004; 43: 1029-1034.
13. Cardoso CRL, Salles GF, Deccache W. QTc interval prolongation is a predictor of future strokes in patients with type 2 diabetes mellitus. Stroke 2003; 34: 2187-2194.
14. Salles GF, Bloch KV, Cardoso CRL. Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetes mellitus patients. Diab Care 2004; 27: 1299-1305.
15. Schillaci G et al. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580-586.
16. Cardoso C et al. Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Int J Cardiol 2001; 79: 253-262.
17. Salles GF, Cardoso CRL, Deccache W. Multivariate associates of QT interval parameters in diabetic patients with arterial hypertension: importance of left ventricular mass and geometric patterns. J Hum Hypertens 2003; 17: 561-567.
18. Day CP, McComb JM, Campbell RWF. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63: 342-344.
19. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
20. Levy D et al. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol 1987; 59: 956-960.
21. Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analysis. Am J Epidemiol 1995; 142: 1255-1264.
22. Concato J, Feinstein AR, Holford TR. The risk of determining risk in multivariate models. Ann Intern Med 1993; 118: 201-210.
23. Kors JA, van Herpen G, van Bemmel JH. QT dispersion as an attribute of T-loop morphology. Circulation 1999; 99: 1458-1463.
24. Lee KW, Kligfield P, Dower GE, Okin. QT dispersion, T wave projection, and heterogeneity of repolarization in patients with coronary artery disease. Am J Cardiol 2001; 87: 148-151.
25. Rana BS et al. Relation of QT-interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiol 2002; 90: 483-487.
26. Messerli FH, Grodzicki T. Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death. Eur Heart J 1992; 13(suppl D): 66-69.
27. Curb JD et al. Sudden death, impaired glucose tolerance and diabetes in Japanese American men. Circulation 1995; 91: 2591-2595.
28. Okin PM et al. Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians. The Strong Heart Study. Hypertension 2004; 43: 769-774.
29. Gueyffier F et al. Identification of risk factors in hypertensive patients. Contribution of randomized controlled trials through an individual patient database. Circulation 1999; 100 e88-e94.
30. Florkowski CM, Scott RS, Coope PA, Moir CL. Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study. Diab Res Clin Prac 2001; 53: 113-120.
31. Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 1999; 159: 585-592.
32. Verdecchia P et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI Study. J Am Coll Cardiol 2001; 38: 1829-1835.
33. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-387.
34. Clement DL et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407-2415.
35. Kors JA et al. T axis as an indicator of risk of cardiac events in elderly people. Lancet 1998; 352: 601-605.
36. Zabel M et al. Analysis of T-wave morphology from the 12-lead electrocardiogram for prediction of long-term prognosis in male US veterans. Circulation 2002; 105: 1066-1070.
37. Okin PM et al. Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes. The Strong Heart Study. Diabetes 2004; 53: 434-440.